Seminars in Radiation Oncology
Volume 17, Issue 3 , Pages 158-168, July 2007

Cutaneous Lymphomas

  • Benjamin D. Smith, MD

      Affiliations

    • United States Air Force, Wilford Hall Medical Center, Lackland AFB, TX.
  • ,
  • Lynn D. Wilson, MD, MPH

      Affiliations

    • Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.
    • Corresponding Author InformationAddress reprint requests to Lynn D. Wilson, MD, MPH, Department of Therapeutic Radiology, Yale University School of Medicine, HRT 132, 333 Cedar Street, New Haven, CT 06520.

The skin is the most common site of extranodal non-Hodgkin lymphoma, with a yearly incidence approaching 1 per 100,000 individuals in the United States. Skin lymphomas are classified broadly into cutaneous T-cell lymphoma (CTCL) and cutaneous B-cell lymphoma (CBCL). Within these broad categories, multiple unique pathologic entities exist with a wide array of natural histories and treatment options. Radiotherapy plays an important role in the curative treatment of localized CTCL and CBCL and may be used to palliate cutaneous and visceral symptoms associated with advanced disease. This review highlights the role of radiotherapy in the multidisciplinary management of cutaneous lymphoma.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(07)00012-4

doi:10.1016/j.semradonc.2007.02.001

Seminars in Radiation Oncology
Volume 17, Issue 3 , Pages 158-168, July 2007